Abstract
Leishmaniasis is caused by protozoan parasites belonging to the genus Leishmania. According to WHO, leishmaniasis occurs in four continents and is considered to be endemic in 88 countries, 72 of which are developing countries. Intensive effort to investigate novel compounds to counter the parasites that are resistant to existing drug molecules is necessary. This review intends to give an outline of the present state of knowledge on antileishmanial drugs along with molecules that are currently under development as promising drug candidate. A brief discussion on some aspects of associated drug resistance is also considered.
Keywords: Leishmaniasis, parasitic protozoa, amastigote, diffuse cutaneous leishmaniasis (DCL), disseminated, phlebotomine sandfly, Chemotherapy, visceral and cutaneous sites of infection, immunocompromised patient, AIDS
Letters in Drug Design & Discovery
Title:Small Molecules Antileishmanials: A Review
Volume: 9 Issue: 5
Author(s): Akanksha Kulshrestha, Meenakshi Dhanawat, Nirupam Das, Sushant K. Shrivastava
Affiliation:
Keywords: Leishmaniasis, parasitic protozoa, amastigote, diffuse cutaneous leishmaniasis (DCL), disseminated, phlebotomine sandfly, Chemotherapy, visceral and cutaneous sites of infection, immunocompromised patient, AIDS
Abstract: Leishmaniasis is caused by protozoan parasites belonging to the genus Leishmania. According to WHO, leishmaniasis occurs in four continents and is considered to be endemic in 88 countries, 72 of which are developing countries. Intensive effort to investigate novel compounds to counter the parasites that are resistant to existing drug molecules is necessary. This review intends to give an outline of the present state of knowledge on antileishmanial drugs along with molecules that are currently under development as promising drug candidate. A brief discussion on some aspects of associated drug resistance is also considered.
Export Options
About this article
Cite this article as:
Akanksha Kulshrestha, Meenakshi Dhanawat, Nirupam Das, Sushant K. Shrivastava , Small Molecules Antileishmanials: A Review, Letters in Drug Design & Discovery 2012; 9 (5) . https://dx.doi.org/10.2174/157018012800389359
DOI https://dx.doi.org/10.2174/157018012800389359 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Surgical Strategies for Fertility Preservation in Women with Cancer
Current Women`s Health Reviews Targeted Drug Delivery in Brain Tumors-nanochemistry Applications and Advances
Current Topics in Medicinal Chemistry Patient-Specific Modeling and Multi-Scale Blood Simulation for Computational Hemodynamic Study on the Human Cerebrovascular System
Current Pharmaceutical Biotechnology Biodegradable Stimuli-Responsive Polymeric Micelles for Treatment of Malignancy
Current Pharmaceutical Biotechnology Unmet Needs in Schizophrenia
CNS & Neurological Disorders - Drug Targets The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments
Mini-Reviews in Medicinal Chemistry Genomic and Non-genomic Effects of Aldosterone
Current Signal Transduction Therapy Marine Peptides for Preventing Metabolic Syndrome
Current Protein & Peptide Science Synthetic Aziridines in Medicinal Chemistry: A Mini-Review
Mini-Reviews in Medicinal Chemistry Sesame Seed Lignans: Potent Physiological Modulators and Possible Ingredients in Functional Foods & Nutraceuticals
Recent Patents on Food, Nutrition & Agriculture Capsaicin-Sensitive Nociceptive Innervation of the Dura Mater: Implications for the Pathomechanism of Headache
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Antioxidant Treatment and Endothelial Dysfunction: Is it Time for Flavonoids?
Recent Patents on Cardiovascular Drug Discovery A Review: The Anti-inflammatory, Anticancer and Antibacterial Properties of Four Kinds of Licorice Flavonoids Isolated from Licorice
Current Medicinal Chemistry Contribution of Transcriptome to Elucidate the Biology of Plasmodium spp
Current Topics in Medicinal Chemistry State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers
Recent Patents on Anti-Infective Drug Discovery Nitric Oxide Synthase and Cyclooxygenase Pathways: A Complex Interplay in Cellular Signaling
Current Medicinal Chemistry Hypotensive Natural Products: Current Status
Mini-Reviews in Medicinal Chemistry Potential Clinical Applications of (-), (+) and (±)-Z-Bisdehydrodoisynolic Acids in Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Chemical Biology: Past, Present and Future
Current Chemical Biology